Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year

British Journal of Ophthalmology

Volumn 87, Issue 2, 2003, Pages 147-148

  Gaynor, Bruce D ^a   Holbrook, K A ^b   Whitcher, J P ^a   Holm, S O ^a   Jha, H C ^c   Chaudhary, J S P ^c   Bhatta, R C ^c   Lietman, T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^c Geta Eye Hospital   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; COTRIMOXAZOLE; MACROLIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; COMMUNICABLE DISEASE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NASOPHARYNX; NEPAL; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; TRACHOMA; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; NEPAL; PREVALENCE; RURAL HEALTH; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; TRACHOMA;

EID: 0037311242     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.2.147     Document Type: Article

References (15)

1. Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet 1999;354:630-5.
2. Laming AC, Currie BJ, DiFrancesco M, et al. A targeted, single-dose azithromycin strategy for trachoma. Med J Aust 2000;172:163-6.
3. Bailey RL, Arullendran P, Whittle HC, et al. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 1993;342:453-6.
4. Dawson CR, Schachter J, Sallam S, et al. A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. Clin Infect Dis 1997;24:363-8.
5. Tabbara KF, Abu-el-Asrar A, al-Omar O, et al. Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study. Ophthalmology 1996;103:842-6.
6. Osaki Holm S, Jha HC, Bhatta RC, et al. A comparison of two azithromycin distribution strategies for trachoma. Bull World Health Organ 2001 (in press).
7. World Health Organization. Report of the first meeting of the WHO alliance for the global elimination of trachoma. Geneva: WHO, 1997.
8. Lietman T, Porco T, Dawson C, et al. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat Med 1999;5:572-6.
9. Oster P, Zanchi A, Cresti S, et al. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. Antimicrob.Agents Chemother 1999;43:2510-2.
10. Doern GV, Pfaller MA, Kugler K, et al. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis 1998;27:764-70.
11. Thornsberry C, Jones ME, Hickey ML, et al. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998. J Antimicrob Chemother 1999;44:749-59.
12. Chern KC, Shrestha SK, Cevallos V, et al. Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area. Br J Ophthalmol 1999;83:1332-5.
13. Leach AJ, Shelby-James TM, Mayo M, et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis 1997;24:356-62.
14. Thylefors B, Dawson CR, Jones BR, et al. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 1987;65:477-83.
15. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997;337:441-6.